Cardiff Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8.54	17.47	51.47	21.66	16.35	11.94
Short-Term Investments	37.51	40.83	40.28	53.17	88.92	128.88
Cash & Short-Term Investments	46.06	58.3	91.75	74.82	105.27	140.82
Cash Growth	-42.35%	-36.45%	22.62%	-28.92%	-25.25%	7.51%
Accounts Receivable	0.19	0.18	0.77	0.29	0.77	0.54
Other Current Assets	1.1	1.64	2.54	2.3	5.25	4.77
Total Current Assets	47.34	60.13	95.05	77.41	111.28	146.13
Net Property, Plant & Equipment	0.99	1.21	2.07	2.95	3.52	3.18
Other Long-Term Assets	0.84	0.55	0.07	1.28	1.39	0.24
Total Assets	49.17	61.88	97.19	81.64	116.19	149.54
Accounts Payable	5.48	8.09	4.82	1.97	1.96	1.44
Accrued Expenses	8.34	7.58	7.9	7.78	5.18	4.53
Current Portion of Leases	0.65	0.73	0.71	0.69	0.68	0.55
Other Current Liabilities	-	-	-	-	-	0.04
Total Current Liabilities	14.46	16.39	13.43	10.44	7.81	6.56
Long-Term Leases	-	0.1	0.81	1.46	2.04	2.57
Total Long-Term Liabilities	-	0.1	0.81	1.46	2.04	2.57
Total Liabilities	14.46	16.5	14.24	11.9	9.85	9.13
Preferred Stock	-	-	-	-	-	0
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-in Capital	477.13	475.36	467.09	409.34	404.83	400.5
Accumulated Other Comprehensive Income	-0.05	0.05	0.03	-0.07	-0.4	-0.14
Retained Earnings	-442.38	-430.03	-384.18	-339.54	-298.1	-259.81
Shareholders' Equity	34.71	45.39	82.95	69.74	106.34	140.42
Total Liabilities & Equity	49.17	61.88	97.19	81.64	116.19	149.54
Total Debt	0.65	0.83	1.52	2.15	2.72	3.12
Net Cash (Debt)	45.41	57.47	90.22	72.67	102.55	137.7
Net Cash Growth	-42.18%	-36.30%	24.15%	-29.13%	-25.53%	5.83%
Net Cash Per Share	0.68	0.86	1.89	1.63	2.35	3.53
Book Value	34.71	45.39	82.95	69.74	106.34	140.42
Book Value Per Share	0.52	0.68	1.74	1.56	2.44	3.60
Tangible Book Value	34.71	45.39	82.95	69.74	106.34	140.42
Tangible Book Value Per Share	0.52	0.68	1.74	1.56	2.44	3.60

SEC Filings: 10-K · 10-Q